Clinical Group

Annals of Alzheimer's and Dementia Care  Open Access

    Recent articles to be released shortly in Volume-3

    Microtubule-associated protein 1B rescues memory decline in Alzheimer’s disease model mice CrossMark

    DOI Logo 10.17352/aadc.000005

    Published On: September 18, 2018 | Pages: 001 - 006

    Author(s): Yoshimi Mitsuyama, Tadashi Koide, Tetsuo Kanno, Shizuko Nagao, Takayuki Manabe and Fuyuki Mitsuyama*
    Background: The classic pathologies seen in Alzheimer’s disease (AD) are amyloid plaques and neurofibrillary tangles, but synapse and spine loss have been recognised as new pathologies. Microtubules are thought to be less plentiful in spines, so it has been thought that spine shape change and molecular transportation in spines is performed mainly by actin. However, re ...
    Abstract View Full Article View Get Citation

    Citicoline in Vascular Cognitive Impairment: Some Latest Evidences CrossMark

    DOI Logo 10.17352/aadc.000004

    Published On: July 17, 2017 | Pages: 018 - 019

    Author(s): Pietro Gareri* and Alberto Castagna
    CDP-choline (cytidine-5′-diphosphate choline), also called citicoline, is one of the most frequently pre scribed drugs for cognitive impairment in several European countries and worldwide. ...
    Abstract View Full Article View Get Citation

    Case Report of Clinically Probable Sporadic Creutzfeldt - Jakob Disease from A Tertiary Care Hospital in South India CrossMark

    DOI Logo 10.17352/aadc.000003

    Published On: April 03, 2017 | Pages: 013 - 017

    Author(s): Shaik Afsar Pasha, Ankamma Rao, Phani Bhushan, Bhaskara Rao B and Prasunpriya Nayak*
    We are reporting an otherwise healthy lady of forty eight years suffering from rapidly progressive dementia, behavioural disturbances, myoclonus, ataxia and extrapyramidal features of eight months duration with characteristic abnormalities on brain imaging, electroencephalography with positive cerebrospinal fluid 14-3-3 protein, satisfying the revised World Health org ...
    Abstract View Full Article View Get Citation

    Can Exposure to Volatile Anesthetics Be a Tipping Point for AD Susceptible Populations? CrossMark

    DOI Logo 10.17352/aadc.000002

    Published On: February 22, 2017 | Pages: 007 - 012

    Author(s): Ingrid R Niesman*
    The relationship between surgery induced Postoperative Cognitive Dysfunction (POCD) and the development of Alzheimer’s disease (AD) later has been a debatable question. Volatile anesthetics represent a potential environmental factor that can change the CNS both acutely and long-term. ...
    Abstract View Full Article View Get Citation

    Amisulpride in Refractory Behavioral and Psychological Symptoms of Dementia CrossMark

    DOI Logo 10.17352/aadc.000001

    Published On: January 03, 2017 | Pages: 001 - 006

    Author(s): Vikas Dhikav*, Dolly Prajapati, Wasifa Muzaffar, Nidhi Agarwal, Sekh Raisuddin, Kuljeet Singh Anand
    Background: Amisulpiride is an atypical antipsychotic used extensively in Schizophrenia and related disorders. The current study explored the safety and tolerability of amisulpride in refractory patients with behavioral and psychological symptoms of dementia (BPSD), especially in agitation and/or aggression. ...
    Abstract View Full Article View Get Citation


    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on AADC